Phase II trial of etoposide in the management of advanced and recurrent leiomyosarcoma of the uterus: a Gynecologic Oncology Group Study.
Slayton
R E
RE
Department of Medicine, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL.
Blessing
J A
JA
Angel
C
C
Berman
M
M
D000328:Adult; D000368:Aged; D005047:Etoposide / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007890:Leiomyosarcoma / Q000188:drug therapy*; D008875:Middle Aged; D014594:Uterine Neoplasms / Q000188:drug therapy*
D005047:Etoposide